# A Study of the Effect of INCB013739 on Cortisone Reducing Enzyme Activity in Obese People Predisposed to Diabetes

> **NCT00398619** · PHASE1 · COMPLETED · sponsor: **Incyte Corporation**

## Conditions studied

- Insulin Resistance
- Obesity

## Interventions

- **DRUG:** INCB13739

## Key facts

- **NCT ID:** NCT00398619
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** — (—)
- **Last updated:** 2012-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00398619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00398619, "A Study of the Effect of INCB013739 on Cortisone Reducing Enzyme Activity in Obese People Predisposed to Diabetes". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00398619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*